Biogen Profit Beats Estimates, Raises 2013 Forecast

25.04.2013 - Biogen reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera becoming...